Literature DB >> 31505512

Reply to the Letter to the Editor "Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease".

Orkide Kutlu1, Özgür Altun1, Okan Dikker2, Şerife Aktaş3, Neslihan Özsoy1, Yücel Arman1, Eylem Özgün Çil1, Mustafa Özcan1, Şengül Aydın Yoldemir1, Murat Akarsu1, İlkim Deniz Toprak1, Kerem Kırna3, Yasin Kutlu1, Zeki Toprak4, Hasan Eruzun5, Tufan Tükek6.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31505512      PMCID： PMC7024875          DOI： 10.1159/000502106

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN： 1011-7571            Impact factor:   1.927


× No keyword cloud information.
  3 in total

1.  Adropin is a novel regulator of endothelial function.

Authors:  Fina Lovren; Yi Pan; Adrian Quan; Krishna K Singh; Praphulla C Shukla; Milan Gupta; Mohammed Al-Omran; Hwee Teoh; Subodh Verma
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

2.  Serum Adropin Levels Are Reduced in Adult Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Orkide Kutlu; Özgür Altun; Okan Dikker; Şerife Aktaş; Neslihan Özsoy; Yücel Arman; Eylem Özgün Çil; Mustafa Özcan; Şengül Aydın Yoldemir; Murat Akarsu; İlkim Deniz Toprak; Kerem Kırna; Yasin Kutlu; Zeki Toprak; Hasan Eruzun; Tufan Tükek
Journal:  Med Princ Pract       Date:  2019-04-16       Impact factor: 1.927

3.  Association between serum adropin level and burden of coronary artery disease in patients with non-ST elevation myocardial infarction.

Authors:  Ahmet Göktuğ Ertem; Sefa Ünal; Tolga Han Efe; Burak Açar; Çağrı Yayla; Mevlüt Serdar Kuyumcu; Özgür Kırbaş; Cemal Köseoğlu; Mehmet Kadri Akboğa; Kadriye Gayretli Yayla; Serkan Gökaslan; Sinan Aydoğdu
Journal:  Anatol J Cardiol       Date:  2016-09-28       Impact factor: 1.596
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.